These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 25518715)

  • 1. Vectors expressing chimeric Japanese encephalitis dengue 2 viruses.
    Wei Y; Wang S; Wang X
    Acta Virol; 2014; 58(4):340-7. PubMed ID: 25518715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and preliminary investigation of a novel dengue serotype 4 chimeric virus using Japanese encephalitis vaccine strain SA14-14-2 as the backbone.
    Li Z; Yang H; Yang J; Lin H; Wang W; Liu L; Zhao Y; Liu L; Zeng X; Yu Y; Li Y
    Virus Res; 2014 Oct; 191():10-20. PubMed ID: 25091563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immunogenicity of tetravalent dengue DNA vaccine in mice pre-exposed to Japanese encephalitis or Dengue virus antigens.
    Prompetchara E; Ketloy C; Keelapang P; Sittisombut N; Ruxrungtham K
    Asian Pac J Allergy Immunol; 2015 Sep; 33(3):182-8. PubMed ID: 26342114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of an assay for detection of Japanese encephalitis virus specific antibody responses.
    Pushpakumara PD; Jeewandara C; Gomes L; Perera Y; Wijewickrama A; Malavige GN; Goonesekara C
    PLoS One; 2020; 15(10):e0238609. PubMed ID: 33112881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A chimeric dengue virus vaccine using Japanese encephalitis virus vaccine strain SA14-14-2 as backbone is immunogenic and protective against either parental virus in mice and nonhuman primates.
    Li XF; Deng YQ; Yang HQ; Zhao H; Jiang T; Yu XD; Li SH; Ye Q; Zhu SY; Wang HJ; Zhang Y; Ma J; Yu YX; Liu ZY; Li YH; Qin ED; Shi PY; Qin CF
    J Virol; 2013 Dec; 87(24):13694-705. PubMed ID: 24109223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fusion PCR generated Japanese encephalitis virus/dengue 4 virus chimera exhibits lack of neuroinvasiveness, attenuated neurovirulence, and a dual-flavi immune response in mice.
    Mathenge EGM; Parquet MDC; Funakoshi Y; Houhara S; Wong PF; Ichinose A; Hasebe F; Inoue S; Morita K
    J Gen Virol; 2004 Sep; 85(Pt 9):2503-2513. PubMed ID: 15302944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Construcion of a chimeric Japanese encephalits virus/dengue virus-2].
    Wei Y; Lu P; Yu JS; Li JD; Liu QZ; Zhang QF; Li C; Miao F; Zhang S; Hang XT; Li DX
    Bing Du Xue Bao; 2009 May; 25(3):185-9. PubMed ID: 19634760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel dengue virus serotype 1 vaccine candidate based on Japanese encephalitis virus vaccine strain SA14-14-2 as the backbone.
    Yang H; Li Z; Lin H; Wang W; Yang J; Liu L; Zeng X; Wu Y; Yu Y; Li Y
    Arch Virol; 2016 Jun; 161(6):1517-26. PubMed ID: 26976137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Japanese encephalitis vaccine-facilitated dengue virus infection-enhancement antibody in adults.
    Saito Y; Moi ML; Takeshita N; Lim CK; Shiba H; Hosono K; Saijo M; Kurane I; Takasaki T
    BMC Infect Dis; 2016 Oct; 16(1):578. PubMed ID: 27756212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chimeric flaviviruses: novel vaccines against dengue fever, tick-borne encephalitis, and Japanese encephalitis.
    Lai CJ; Monath TP
    Adv Virus Res; 2003; 61():469-509. PubMed ID: 14714441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chimeric Japanese encephalitis virus/dengue 2 virus infectious clone: biological properties, immunogenicity and protection against dengue encephalitis in mice.
    Chambers TJ; Jiang X; Droll DA; Liang Y; Wold WSM; Nickells J
    J Gen Virol; 2006 Nov; 87(Pt 11):3131-3140. PubMed ID: 17030845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of new vaccines against dengue fever and Japanese encephalitis.
    Kinney RM; Huang CY
    Intervirology; 2001; 44(2-3):176-97. PubMed ID: 11509879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of chimeric DNA vaccines consisting of premembrane and envelope genes of Japanese encephalitis and dengue viruses as a strategy for reducing induction of dengue virus infection-enhancing antibody response.
    Sjatha F; Kuwahara M; Sudiro TM; Kameoka M; Konishi E
    Microbiol Immunol; 2014 Feb; 58(2):126-34. PubMed ID: 24372832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Construction of a full-length cDNA clone of a live attenuated vaccine strain against Japanese encephalitis virus and preliminary study of expressing exogenous gene].
    Hu B; Yang S; Fang ZZ
    Bing Du Xue Bao; 2014 Nov; 30(6):652-60. PubMed ID: 25868280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody-dependent enhancement (ADE) of dengue virus: Identification of the key amino acid that is vital in DENV vaccine research.
    Cui G; Si L; Wang Y; Zhou J; Yan H; Jiang L
    J Gene Med; 2021 Feb; 23(2):e3297. PubMed ID: 33217097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Japanese encephalitis virus prM-E antigen immunization conferred protection against challenge by four different serotypes of Dengue viruses in mice.
    Gao N; Li J; Sheng Z; Chen H; Fan D; Wang P; An J
    Appl Microbiol Biotechnol; 2019 Jun; 103(12):4977-4986. PubMed ID: 31037380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses.
    Guy B; Guirakhoo F; Barban V; Higgs S; Monath TP; Lang J
    Vaccine; 2010 Jan; 28(3):632-49. PubMed ID: 19808029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chimeric classical swine fever (CSF)-Japanese encephalitis (JE) viral replicon as a non-transmissible vaccine candidate against CSF and JE infections.
    Yang Z; Wu R; Li RW; Li L; Xiong Z; Zhao H; Guo D; Pan Z
    Virus Res; 2012 Apr; 165(1):61-70. PubMed ID: 22285514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Japanese encephalitis virus vaccine candidates generated by chimerization with dengue virus type 4.
    Gromowski GD; Firestone CY; Hanson CT; Whitehead SS
    Vaccine; 2014 May; 32(25):3010-8. PubMed ID: 24699473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substitution of the precursor peptide prevents anti-prM antibody-mediated antibody-dependent enhancement of dengue virus infection.
    Wang Y; Si LL; Guo XL; Cui GH; Fang DY; Zhou JM; Yan HJ; Jiang LF
    Virus Res; 2017 Feb; 229():57-64. PubMed ID: 27939945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.